COTA: Website lets you opt out of an overstuffed holiday mailbox

Back to TopCommentsE-mailPrintBookmark and Share
Jim Cota

It’s that time of year again and, to be honest, it drives me crazy.

It seems like every day for the past month, I’ve come home to find the mailbox overflowing with catalogs from every type of retailer you can imagine. (If my mailbox is any indication, news of the death of the printing industry is greatly exaggerated.)

I should note that I make a living helping people sell things, so I understand the necessity of telling people about goods and their prices. But we have reached a point of both enlightenment and technology that allows for much better methods. Until the retailers catch on, we need someone out there trying to cut down on the catalog deluge.

Catalog Choice to the rescue.

Similar to do-not-call lists and e-mail opt-out lists, Catalog Choice (www.catalogchoice.org) lets you opt out of catalogs. It’s a free service that allows you to decide what arrives in your mailbox. Catalog Choice is a TrustedID company, based in Berkeley, Calif. As part of TrustedID, Catalog Choice provides a core component of the nation’s most comprehensive identity protection, privacy and junk-mail reduction service.

I’ve been a fan of Catalog Choice since it launched in 2007. Its mission is to reduce the number of unsolicited catalog mailings and promote the adoption of sustainable industry best practices. And it’s had some success: It claims to have saved 800,000 trees, 118 million pounds of solid waste, and 800 million gallons of water. Not bad.

The great thing about the service (aside from being free), is that it’s ridiculously easy to use. Simply log in, find the catalog you’d like to opt-out from, and enter your customer number from your mailing label. It works even if you don’t have the number. Can’t find the catalog you’re looking for? Add it to the database.

Of course, Catalog Choice can’t declutter your mailbox on its own. One of the more unfortunate practices of direct-mail companies is their habit of selling their lists to boost revenue. It works something like this: They send out their catalogs to everyone who ever purchased anything. If sales start to slip, they look to the one asset they have that is guaranteed to provide a return: the database of information they’ve collected about their customers. That’s why, even if you cancel your Victoria’s Secret catalog, tomes may show up next year from companies you never heard of or ordered from.

So while it can’t solve the problem entirely, it can cut down on the material you are sending directly to the recycling bin. Behind the scenes, Catalog Choice is working with major players in the industry to pass along your preferences and ensure that they comply with your requests. There are a dwindling few who refuse to play nice, but for the most part, anyone who is in the business understands the futile nature of spending money mailing catalogs to someone who doesn’t want them. Most have given up the vain hope that maybe, just maybe, we’ll see something in this catalog that will spur us to order again, even though we haven’t done so in six years.

What I’ve realized (now that my mailbox has gradually filled up again) is that you need to occasionally update your settings to ensure that the mailings don’t return. It generally takes about 90 days to process your request, so if you do it now, you should stop the deluge just in time for Mother’s Day.•


Cota is president and co-founder of Rare Bird Inc., a marketing communications firm specializing in Internet application development. His column appears monthly. He can be reached at jim@rarebirdinc.com.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

  2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

  3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

  4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

  5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?